Seeing Is Believing
CSBR is currently covered by 1 analysts with an average price target of $8.32. This is a potential upside of $2.1 (33.76%) from yesterday's end of day stock price of $6.22.
Champions Oncology's activity chart (see below) currently has 3 price targets and 4 ratings on display. The stock rating distribution of CSBR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 281 days.
Highest price target for CSBR is $5, Lowest price target is $5, average price target is $7.5.
Most recent stock forecast was given by SCOTT HENRY from ROTH on 22-Sep-2023. First documented stock forecast 20-Sep-2019.
Currently out of the existing stock ratings of CSBR, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$7.5
$1.28 (20.58%)
$16
1 years 7 months 19 days ago
(22-Sep-2023)
2/3 (66.67%)
$2.1 (38.89%)
281
What is CSBR (Champions Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on CSBR (Champions Oncology) with a proven track record?
Which analyst has the most public recommendations on CSBR (Champions Oncology)?
Which analyst is the currently most bullish on CSBR (Champions Oncology)?